EXPLORING THE EFFICACY AND THERAPEUTIC POTENTIAL OF MESENCHYMAL STEM CELL–DERIVED EXOSOMES FOR THE TREATMENT OF ANDROGENIC ALOPECIA
Main Article Content
Keywords
.
Abstract
Introduction: Androgenic alopecia, a form of hair loss driven by genetic predisposition and hormonal influences, is the most common cause of hair thinning and baldness in both men and women.
Objectives: The main objective of the study is to find the efficacy and therapeutic potential of mesenchymal stem cell–derived exosomes for the treatment of androgenic alopecia.
Methodology of the study: This Randomized control trial was conducted at different aesthetics clinics and patients provide the data during 2023 to June 2024. A total of 85 patients, aged between 18 and 55 years, with clinically diagnosed androgenic alopecia (Norwood-Hamilton classification II–V for men, and Ludwig classification I–II for women) were enrolled. Participants with stable hair loss patterns for at least one year and had not undergone any hair loss treatments (such as minoxidil or finasteride) in the six months were included in the study.
Results: The treatment group showed a significant increase in hair density, with a mean increase of 35 hairs/cm² over 12 weeks, compared to their baseline density of 100 hairs/cm². This change is statistically significant, as indicated by a p-value of 0.001. In contrast, the placebo group exhibited a negligible increase in hair density, with a mean increase of just 3 hairs/cm², suggesting the effectiveness of the treatment over the placebo.
Conclusion: It is concluded that mesenchymal stem cell-derived exosomes significantly enhance hair density and thickness in patients with androgenic alopecia, offering a promising and well-tolerated treatment option.
References
2. Oryan A, Sahvieh S. Effectiveness of chitosan scaffold in skin, bone and cartilage healing. Int J Biol Macromol. 2017;104(Pt A):1003–1011. doi: 10.1016/j.ijbiomac.2017.06.124.
3. Guo SC, Tao SC, Yin WJ, Qi X, Yuan T, Zhang CQ. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics. 2017;7(1):81–96. doi: 10.7150/thno.16803.
4. Wang L, Hu L, Zhou X, Xiong Z, Zhang C, Shehada HMA, Hu B, Song J, Chen L. Exosomes secreted by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling. Sci Rep. 2017;7:13321. doi: 10.1038/s41598-017-12919-x.
5. Zhao B, Zhang Y, Han S, Zhang W, Zhou Q, Guan H, Liu J, Shi J, Su L, Hu D. Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation. J Mol Histol. 2017;48(2):121–132. doi: 10.1007/s10735-017-9711-x.
6. Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27(3):172–188. doi: 10.1016/j.tcb.2016.11.003.
7. Toh WS, Lai RC, Hui JHP, Lim SK. MSC exosome as a cell-free MSC therapy for cartilage regeneration: implications for osteoarthritis treatment. Semin Cell Dev Biol. 2017;67:56–64. doi: 10.1016/j.semcdb.2016.11.008.
8. Zhang S, Chu WC, Lai RC, Lim SK, Hui JHP, Toh WS. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 2018;156:16–27. doi: 10.1016/j.biomaterials.2017.11.028.
9. Phan J, Kumar P, Hao D, Gao K, Farmer D, Wang A. Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. J Extracell Vesicles. 2018;7(1):1522236. doi: 10.1080/20013078.2018.1522236.
10. Zhang W, Bai X, Zhao B, Li Y, Zhang Y, Li Z, Wang X, Luo L, Han F, Zhang J, Han S, Cai W, Su L, Tao K, Shi J, Hu D. Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway. Exp Cell Res. 2018;370:333–342. doi: 10.1016/j.yexcr.2018.06.035.
11. Saury C, Lardenois A, Schleder C, Leroux I, Lieubeau B, David L, Charrier M, Guével L, Viau S, Delorme B, Rouger K. Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches. Stem Cell Res Ther. 2018;9(1):128. doi: 10.1186/s13287-018-0852-y.
12. Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824–833. doi: 10.1016/j.stem.2018.05.004.
13. Phan J, Kumar P, Hao D, Gao K, Farmer D, Wang A. Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. J Extracell Vesicles. 2018;7(1):1522236. doi: 10.1080/20013078.2018.1522236.
14. Watson DC, Yung BC, Bergamaschi C, Chowdhury B, Bear J, Stellas D, Morales-Kastresana A, Jones JC, Felber BK, Chen X, Pavlakis GN. Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes. J Extracell Vesicles. 2018;7(1):1442088. doi: 10.1080/20013078.2018.1442088.
15. Bijukumar DR, McGeehan C, Mathew MT. Regenerative medicine strategies in biomedical implants. Curr Osteoporos Rep. 2018;16(3):236–245. doi: 10.1007/s11914-018-0441-0.
16. Hoang DTN, Nguyen THP, Quynh Do TT, et al. Comparative characterization of exosomes secreted from various mesenchymal stem cells and their effects on cutaneous wound healing. Stem Cell Res Ther. 2021;12(1):232.
17. Su N, Hao Y, Wang F, Hou W, Chen H, Luo Y. Mesenchymal stromal exosome-functionalized scaffolds induce innate and adaptive immunomodulatory responses toward tissue repair. Sci Adv. 2021;7(20)
18. Zhang Y, Yan J, Liu Y, Chen Z, Li X, Tang L, Li J, Duan M, Zhang G. Human amniotic fluid stem cell-derived exosomes as a novel cell-free therapy for cutaneous regeneration. Front Cell Dev Biol. 2021;9:685873. doi: 10.3389/fcell.2021.685873.
19. Tutuianu R, Rosca AM, Iacomi DM, Simionescu M, Titorencu I. Human mesenchymal stromal cell-derived exosomes promote in vitro wound healing by modulating the biological properties of skin keratinocytes and fibroblasts and stimulating angiogenesis. Int J Mol Sci. 2021;22(12):6239. doi: 10.3390/ijms22126239.
20. Liu A, Lin D, Zhao H, Chen L, Cai B, Lin K, Shen SG. Optimized BMSC-derived osteoinductive exosomes immobilized in hierarchical scaffold via lyophilization for bone repair through Bmpr2/Acvr2b competitive receptor-activated Smad pathway. Biomaterials. 2021;272:120718. doi: 10.1016/j.biomaterials.2021.120718.
21. Hu JC, Zheng CX, Sui BD, Liu WJ, Jin Y. Mesenchymal stem cell-derived exosomes: a novel and potential remedy for cutaneous wound healing and regeneration. World J Stem Cells. 2022;14(5):318–329. doi: 10.4252/wjsc.v14.i5.318.
22. Perez-Meza D, Ziering C, Sforza M, Krishnan G, Ball E, Daniels E. Hair follicle growth by stromal vascular fraction-enhanced adipose transplantation in baldness. Stem Cells Cloning. 2017;10:1-10.
23. Elmaadawi IH, Mohamed BM, Ibrahim ZAS, Abdou SM, El Attar YA, Youssef A, et al. Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia. J Dermatolog Treat. 2018;29:431-440.
24. Shimizu Y, Ntege EH, Sunami H, Inoue Y. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature. Regen Ther. 2022;21:527-539.
25. Hwang I, Choi KA, Park HS, Jeong H, Kim JO, Seol KC, et al. Neural Stem Cells Restore Hair Growth Through Activation of the Hair Follicle Niche. Cell Transplant. 2016;25:1439-1451.